Dr. James Lukban, MD

NPI: 1841266616
Total Payments
$455,282
2024 Payments
$13,520
Companies
6
Transactions
324
Medicare Patients
746
Medicare Billing
$69,174

Payment Breakdown by Category

Research$256,710 (56.4%)
Royalty/License$132,950 (29.2%)
Education$38,551 (8.5%)
Other$11,392 (2.5%)
Travel$6,163 (1.4%)
Consulting$5,606 (1.2%)
Food & Beverage$3,909 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $256,710 154 56.4%
Royalty or License $132,950 31 29.2%
Education $38,551 18 8.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,392 13 2.5%
Travel and Lodging $6,163 28 1.4%
Consulting Fee $5,606 6 1.2%
Food and Beverage $3,909 74 0.9%

Payments by Type

Research
$256,710
154 transactions
General
$198,572
170 transactions

Top Paying Companies

Company Total Records Latest Year
COLOPLAST CORP $449,404 273 $0 (2024)
Caldera Medical, Inc $2,991 6 $0 (2021)
Medtronic USA, Inc. $2,680 35 $0 (2020)
Astellas Pharma US Inc $173.79 8 $0 (2018)
Intuitive Surgical, Inc. $19.89 1 $0 (2020)
Axonics, Inc. $13.20 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $13,520 3 COLOPLAST CORP ($13,520)
2023 $26,780 4 Coloplast Corp ($26,780)
2022 $20,926 4 Coloplast Corp ($20,926)
2021 $56,979 46 COLOPLAST CORP ($56,951)
2020 $50,328 37 Coloplast Corp ($47,462)
2019 $80,215 76 Coloplast Corp ($79,561)
2018 $114,700 109 Coloplast Corp ($112,458)
2017 $91,834 45 Coloplast Corp ($91,746)

All Payment Transactions

324 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
10/18/2024 COLOPLAST CORP Altis (Device) Food and Beverage In-kind items and services $64.84 General
Category: Women's Health
05/15/2024 COLOPLAST CORP Altis (Device) Royalty or License Cash or cash equivalent $6,637.02 General
Category: Women's Health
01/16/2024 COLOPLAST CORP Altis (Device) Royalty or License Cash or cash equivalent $6,818.11 General
Category: Women's Health
11/08/2023 Coloplast Corp Altis (Device) Royalty or License Cash or cash equivalent $6,263.48 General
Category: Women's Health
07/27/2023 Coloplast Corp Altis (Device) Royalty or License Cash or cash equivalent $7,168.48 General
Category: Women's Health
05/01/2023 Coloplast Corp Altis (Device) Royalty or License Cash or cash equivalent $6,738.84 General
Category: Women's Health
02/07/2023 Coloplast Corp Altis (Device) Royalty or License Cash or cash equivalent $6,609.03 General
Category: Women's Health
11/02/2022 Coloplast Corp Altis (Device) Royalty or License Cash or cash equivalent $5,668.06 General
Category: Women's Health
08/22/2022 Coloplast Corp Altis (Device) Royalty or License Cash or cash equivalent $4,724.00 General
Category: Women's Health
05/02/2022 Coloplast Corp Altis (Device) Royalty or License Cash or cash equivalent $4,805.82 General
Category: Women's Health
03/14/2022 Coloplast Corp Altis (Device) Royalty or License Cash or cash equivalent $5,727.70 General
Category: Women's Health
12/15/2021 COLOPLAST CORP Restorelle (Device) Cash or cash equivalent $2,034.00 Research
Study: Restorelle Transvaginal Mesh versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse • Category: Women's Health
11/10/2021 COLOPLAST CORP Restorelle (Device) Cash or cash equivalent $1,017.00 Research
Study: Restorelle Transvaginal Mesh versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse • Category: Women's Health
11/04/2021 COLOPLAST CORP Food and Beverage In-kind items and services $17.63 General
10/22/2021 COLOPLAST CORP Altis (Device) Education Cash or cash equivalent $700.00 General
Category: Women's Health
10/22/2021 COLOPLAST CORP Cash or cash equivalent $350.00 Research
Study: Physician Directed Study
10/20/2021 COLOPLAST CORP Altis (Device) Royalty or License Cash or cash equivalent $4,064.72 General
Category: Women's Health
09/17/2021 COLOPLAST CORP Cash or cash equivalent $1,575.00 Research
Study: Physician Directed Study
08/26/2021 COLOPLAST CORP Cash or cash equivalent $1,400.00 Research
Study: Physician Directed Study
08/19/2021 COLOPLAST CORP Cash or cash equivalent $4,812.50 Research
Study: Physician Directed Study
08/09/2021 COLOPLAST CORP Altis (Device) Cash or cash equivalent $860.50 Research
Study: Altis Single Incision Sling System versus Transobturator or Retropubic Mesh Slings in the Treatement of Stress Urinary Incontinence (Altis 522 Study) • Category: Women's Health
08/08/2021 COLOPLAST CORP Travel and Lodging In-kind items and services $23.19 General
08/07/2021 COLOPLAST CORP Travel and Lodging In-kind items and services $220.07 General
08/07/2021 COLOPLAST CORP Food and Beverage In-kind items and services $23.44 General
08/07/2021 COLOPLAST CORP Food and Beverage In-kind items and services $8.20 General

Research Studies & Clinical Trials

Study Name Company Amount Records
RESTORELLE Coloplast Corp $97,202 57
RESTORELL Coloplast Corp $63,305 23
ALTIS Coloplast Corp $46,973 41
Physician Directed Study COLOPLAST CORP $29,138 14
PHYSICIANS DIRECTED Coloplast Corp $13,221 9
Restorelle Transvaginal Mesh versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse COLOPLAST CORP $3,501 5
Altis Single Incision Sling System versus Transobturator or Retropubic Mesh Slings in the Treatement of Stress Urinary Incontinence (Altis 522 Study) COLOPLAST CORP $3,371 5

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 11 326 417 $101,626 $31,331
2020 14 420 537 $131,896 $37,843
Total Patients
746
Total Services
954
Medicare Billing
$69,174
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
51729 Complex measurement of pressure of urine flow in bladder (cystometrogram) with bladder canal (urethra) pressure and voiding pressure studies Office 2021 18 19 $18,690 $6,351 34.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 51 79 $17,568 $5,121 29.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 42 49 $15,191 $4,883 32.1%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 32 32 $13,227 $3,997 30.2%
51797 Insertion of device into the abdomen with measurement of pressure and urine flow rate Office 2021 18 18 $8,371 $2,877 34.4%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 17 17 $9,147 $2,355 25.7%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 33 54 $7,423 $2,348 31.6%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 13 14 $6,056 $1,991 32.9%
51798 Ultrasound measurement of bladder capacity after voiding Office 2021 68 101 $2,572 $842.93 32.8%
51784 Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings Office 2021 17 17 $2,789 $466.65 16.7%
51741 Electronic assessment of bladder emptying Office 2021 17 17 $592.54 $98.09 16.6%
51729 Insertion of electronic device into bladder with voiding and bladder canal (urethra) pressure studies Office 2020 25 25 $21,723 $7,554 34.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 59 97 $17,257 $5,655 32.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 50 68 $17,627 $5,414 30.7%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 36 36 $14,217 $4,181 29.4%
57240 Repair of herniation of bladder into vaginal wall Facility 2020 11 11 $17,124 $3,780 22.1%
51797 Insertion of device into the abdomen with measurement of pressure and urine flow rate Office 2020 25 25 $8,443 $3,383 40.1%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 12 12 $5,951 $1,848 31.1%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 15 17 $5,915 $1,699 28.7%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 26 41 $4,386 $1,337 30.5%
51798 Ultrasound measurement of bladder capacity after voiding Office 2020 94 135 $4,379 $1,089 24.9%
51784 Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings Office 2020 22 22 $6,251 $613.94 9.8%
52000 Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope Facility 2020 12 12 $6,141 $606.36 9.9%
51701 Insertion of temporary bladder catheter Office 2020 12 15 $1,723 $558.75 32.4%
51741 Electronic assessment of bladder emptying Office 2020 21 21 $757.14 $124.62 16.5%

About Dr. James Lukban, MD

Dr. James Lukban, MD is a Obstetrics & Gynecology healthcare provider based in Englewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841266616.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Lukban, MD has received a total of $455,282 in payments from pharmaceutical and medical device companies, with $13,520 received in 2024. These payments were reported across 324 transactions from 6 companies. The most common payment nature is "" ($256,710).

As a Medicare-enrolled provider, Lukban has provided services to 746 Medicare beneficiaries, totaling 954 services with total Medicare billing of $69,174. Data is available for 2 years (2020–2021), covering 25 distinct procedure/service records.

Practice Information

  • Specialty Obstetrics & Gynecology
  • Location Englewood, CO
  • Active Since 02/23/2006
  • Last Updated 07/21/2022
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1841266616

Products in Payments

  • RESTORELLE (Device) $231,962
  • ALTIS (Device) $98,841
  • Altis (Device) $84,341
  • Restorelle (Device) $3,501
  • Desara (Device) $2,991
  • INTERSTIM (Device) $2,664
  • FEMALE INCONTINENCE (Device) $226.34
  • AXIS (Biological) $175.30
  • Myrbetriq (Drug) $56.66
  • MYRBETRIQ (Drug) $21.37
  • VESICARE (Drug) $20.77
  • Da Vinci Surgical System (Device) $19.89
  • NURO (Device) $16.53
  • Bulkamid (Device) $13.20
  • DIGITEX (Device) $12.44
  • DURASPHERE (Device) $10.07

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Englewood